Hemostatic Disorders of the Newborn

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 1145-1179

  Kuhle, Stefan ^a   Mitchell, Lesley ^b,c   Massicotte, Patricia ^b,c   Andrew, Maureen ^d,e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF ALBERTA   (Canada)

^c STOLLERY CHILDREN S HOSPITAL   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748263621     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50078-0     Document Type: Chapter

References (329)

1. Abdulla F, Dietrich KA, Pramanik AK Percutaneous femoral venous catheterization in preterm neonates. J Pediatr 1990, 117:788-790.
2. al Mofada SM, Osman M, Kides E, et al. Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinatol 1994, 11:423-426.
3. Allaart CF, Poort S, Rosendaal F, et al. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993, 341:134-138.
4. Controversies concerning vitamin K and the newborn. Pediatrics 1993, 91:1001-1003. American Academy of Pediatrics.
5. Andrew M, Brooker L Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996, 10:88-99.
6. Andrew M, Brooker L, Leaker M, et al. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992, 68:325-330.
7. Andrew M, Castle V, Saigal S, et al. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987, 110:457-464.
8. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994, 83:1251-1257.
9. Andrew M, Marzinotto V, Massicotte P, et al. Heparin therapy in pediatric patients: A prospective cohort study. Pediatr Res 1994, 35:78-83.
10. Andrew M, Mitchell L, Berry L, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992, 89:321-326.
11. Andrew M, Ofosu F, Brooker L, et al. The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig. Thromb Res 1989, 56:529-539.
12. Andrew M, Paes B, Bowker J, et al. Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990, 35:275-277.
13. Andrew M, Paes B, Johnston M Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990, 12:95-104.
14. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the fullterm infant. Blood 1987, 70:165-172.
15. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988, 72:1651-1657.
16. Andrew M, Schmidt B, Mitchell L, et al. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990, 63:27-30.
17. Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993, 123:285-291.
18. Ankola PA, Atakent Y Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol 1993, 10:229-232.
19. Ansell JE, Patel N, Ostrovsky D, et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995, 155:2185-2189.
20. Aschka I, Aumann V, Bergmann F, et al. Prevalence of factor V Leiden in children with thromboembolism. Eur J Pediatr 1996, 155:1009-1014.
21. Astedt B, Lindoff C Plasminogen activators and plasminogen activator inhibitors in plasma of premature and term newborns. Acta Paediatr 1997, 86:111-113.
22. Ballin A, Andrew M, Ling E, et al. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988, 112:789-792.
23. Barkovich AJ The encephalopathic neonate: choosing the proper imaging technique. Am J Neuroradiol 1997, 18:1816-1820.
24. Barlow CF, Priebe C, Mulliken J, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998, 132:527-530.
25. Barmada MA, Moossy J, Shuman R Cerebral infarcts with arterial occlusion in neonates. Ann Neurol 1979, 6:495-502.
26. Barrington KJ Umbilical artery catheters in the newborn: effects of heparin. Cochrane. Database Syst Rev 2000, CD000507.
27. Barrington KJ Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev 2000, CD000505.
28. Bartlett RH Extracorporeal Life Support Registry Report 1995. ASAIO J 1997, 43:104-107.
29. Beverley DW, Chance G, Inwood M, et al. Intraventricular haemorrhage and haemostasis defects. Arch Dis Child 1984, 59:444-448.
30. Beverley DW, Pitts-Tucker T, Congdon P, et al. Prevention of intraventricular haemorrhage by fresh frozen plasma. Arch Dis Child 1985, 60:710-713.
31. Bezinque SL, Slovis T, Touchette A, et al. Characterization of superior sagittal sinus blood flow velocity using color flow Doppler in neonates and infants. Pediatr Radiol 1995, 25:175-179.
32. Bignell P, Standen G, Bowen D, et al. Rapid neonatal diagnosis of von Willebrand's disease by use of the polymerase chain reaction. Lancet 1990, 336:638-639.
33. Blanchette VS, Johnson J, Rand M The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol 2000, 13:365-390.
34. Blanchette VS, Kuhne T, Hume H, et al. Platelet transfusion therapy in newborn infants. Transf Med Rev 1995, IX:215-230.
35. Blanchette VS, Rand ML Platelet disorders in newborn infants: Diagnosis and management. Semin Perinatol 1997, 21:53-62.
36. Bokenkamp A, Von Kries R, Nowak-Gottl U, et al. Neonatal renal venous thrombosis in Germany between 1992 and 1994: Epidemiology, treatment and outcome. Eur J Pediatr 2000, 159:44-48.
37. Boo NY, Wong NC, Zulkifli SS, et al. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999, 35:460-465.
38. Bovill EG, Becker R, Tracy RP Monitoring thrombolytic therapy. Prog Cardiovasc Dis 1992, 34:279-294.
39. 1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 1993, 81:77-83.
40. Brenner B, Fishman A, Goldsher D, et al. Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 1988, 27:209-211.
41. Buchanan GR Factor concentrate prophylaxis for neonates with hemophilia. J Pediatr Hematol Oncol 1999, 21:254-256.
42. Bulas DI, Taylor G, O'Donnell R, et al. Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: update on sonographic and CT findings. Am J Neuroradiol 1996, 17:287-294.
43. Burrows RF, Andrew M Neonatal thrombocytopenia in the hypertensive disorders of pregnancy. Obstet Gynecol 1990, 76:234-238.
44. Burrows RF, Kelton J Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 1988, 319:142-145.
45. Burrows RF, Kelton J Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993, 329:1463-1466.
46. Burrows RF, Kelton JG Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura do not justify obstetrical interventions. Am J Obstet Gynecol 1990, 163:1147-1150.
47. Bussel J, Berkowitz RL, MacFarland JG Multicenter study of antenatal management of fetal alloimmune thrombocytopenia (AIT): Stratification into 4 risk groups prior to randomization [abstract]. Thromb Haemost 2001, 86:P1234.
48. Bussel J, Kaplan C, McFarland J, et al. Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. Thromb Haemost 1991, 65:631-634.
49. Bussel JB Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 2001, 27:245-252.
50. Bussel JB, Skupski D, MacFarland J Fetal alloimmune thrombocytopenia: Consensus and controversy. J Matern Fetal Med 1996, 5:281-292.
51. Bussel JB, Zabusky MR, Berkowitz R, et al. Fetal alloimmune thrombocytopenia. N Engl J Med 1997, 337:22-26.
52. Caeton AJ, Goetzman B Risky business. Umbilical arterial catheterization [editorial]. Am J Dis Child 1985, 139:120-121.
53. Calhoun DA, Christensen R, Edstrom C, et al. Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol 2000, 27:733-753.
54. Carcao MD, Blanchette V, Dean JA, et al. The platelet function analyzer (PFA-100): A novel in vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998, 101:70-73.
55. Castle V, Andrew M, Kelton J, et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986, 108:749-755.
56. Castle V, Coates G, Mitchell L, et al. The effect of hypoxia on platelet survival and site of sequestration in the newborn rabbit. Thromb Haemost 1988, 59:45-48.
57. Chait P, Dinyari M, Massicotte MP The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: The LUV study [abstract]. Thromb Haemost 2001, (Suppl):P697.
58. Chan AKC, Leaker M, Burrows F, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997, 77:270-277.
59. Chang GY, Lueder F, DiMichele D, et al. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr 1997, 131:362-366.
60. Chen JP, Lorch V Intraventricular haemorrhage in preterm infants: Evidence of suppressed fibrinolysis. Blood Coagul Fibrinolysis 1996, 7:289-294.
61. Cheung AM, Halton J, Dinyari M Bone mineral density (BMD) in a cohort of children on long term warfarin therapy (.1year). Thromb Haemost 2001, 86. OC1729 (Abstract).
62. Cheung PY, Salas E, Etches P, et al. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 1998, 351:1181-1182.
63. Cheung PY, Sawicki G, Salas E, et al. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 2000, 28:2584-2590.
64. Choi M, Massicotte M, Marzinotto V, et al. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study. J Pediatr 2001, 139:152-156.
65. Chowdhury V, Lane D, Mille B, et al. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb Haemost 1994, 72:198-202.
66. Conway JH, Hilgartner M Initial presentations of pediatric hemophiliacs. Arch Pediatr Adolesc Med 1994, 148:589-594.
67. Cook RL, Miller R, Katz V, et al. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 1991, 78:578-583.
68. Corby DG Aspirin in pregnancy: maternal and fetal effects. Pediatrics 1978, 62:930-937.
69. Corby DG, O'Barr T Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 1981, 2:215-225.
70. Corby DG, O'Barr T Neonatal platelet function: a membrane-related phenomenon?. Haemostasis 1981, 10:177-185.
71. Cornelissen EAM, Steegers-Theunissen R, Kollee LA, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993, 168:884-888.
72. Cornelissen E, Kollee LAA, De Abreu RA, et al. Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr 1993, 82:656-659.
73. Corrigan JJ, Sleeth J, Jeter M, et al. Newborn's fibrinolytic mechanism: components and plasmin generation. Am J Hematol 1989, 32:273-278.
74. Dahlback B Blood coagulation. Lancet 2000, 355:1627-1632.
75. Dasari R, Narang A, Vasishta K, et al. Effect of maternal low dose aspirin on neonatal platelet function. Indian Pediatr 1998, 35:507-511.
76. Debus O, Koch H, Kurlemann G, et al. Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998, 78:F121-F124.
77. Delorme MA, Xu L, Berry L, et al. Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta. Thromb Res 1998, 90:147-153.
78. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994, 72:352-358.
79. de Veber G, Adams M, Andrew M Cerebral thromboembolism in neonates: Clinical and radiographic features [abstract]. Thromb Haemost 1997, 78(suppl.):725.
80. de Veber G, Andrew M Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 345:417-423. the Canadian Pediatric Stroke Study Group.
81. de Veber G, Chan A, Monagle P, et al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998, 55:1533-1537.
82. de Veber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998, 55:1539-1543.
83. de Veber GA, MacGregor D, Curtis R, et al. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000, 15:316-324.
84. de Vries LS, Groenendaal F, Eken P, et al. Infarcts in the vascular distribution of the middle cerebral artery in preterm and fullterm infants. Neuropediatrics 1997, 28:88-96.
85. DiMichele D, Neufeld E Hemophilia. A new approach to an old disease. Hematol Oncol Clin North Am 1998, 12:1315-1344.
86. Dix D, Andrew M, Marzinotto V, et al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000, 136:439-445.
87. Dollery CM, Sullivan I, Bauraind O, et al. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994, 344:1043-1045.
88. Donner M, Holmberg L, Nilsson I Type IIB von Willebrand's disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. Br J Haematol 1987, 66:349-354.
89. Dreyfus M, Magny J, Bridey F, et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991, 325:1565-1568.
90. Edelberg JM, Enghild J, Pizzo S, et al. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. J Clin Invest 1990, 86:107-112.
91. Ekelund H, Hedner U, Nilsson I Fibrinolysis in newborns. Acta Paediatr Scand 1970, 59:33-43.
92. Ellis MR Coagulopathy screening in children with heparinized central venous catheters. Pediatrics 1993, 91:1147-1150.
93. Estan J, Hope P Unilateral neonatal cerebral infarction in full term infants. Arch Dis Child Fetal Neonatal Ed 1997, 76:F88-F93.
94. Farnoux C, Camard O, Pinquier D, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1998, 133:137-140.
95. Important drug warning regarding the use of Abbokinase (urokinase) 1999, Food and Drug Administration (FDA), Public Health Services, Rockville, Md.
96. Forestier F, Daffos F, Galacteros F, et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986, 20:342-346.
97. Francis JL, Armstrong D Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostasis 1982, 11:223-228.
98. Gatti L, Guarneri D, Caccamo M, et al. Platelet activation in newborns detected by flow-cytometry. Biol Neonate 1996, 70:322-327.
99. Gazengel C, Fischer A, Schlegel N, et al. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates. Nouv Rev Fr Hematol 1988, 30:225-227.
100. George TN, Johnson K, Bates J, et al. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998, 132:731-734.
101. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992, 305:341-346.
102. Golding J, Paterson M, Kinlen LJ Factors associated with childhood cancer in a national cohort study. Br J Cancer 1990, 62:304-308.
103. Gopel W, Gortner L, Kohlmann T, et al. Low prevalence of large intraventricular haemorrhage in very low birthweight infants carrying the factor V Leiden or prothrombin G20210A mutation. Acta Paediatr 2001, 90:1021-1024.
104. Greer FR, Marshall S, Cherry J, et al. Vitamin K status of lactating mothers, human milk, and breast-feeding infants. Pediatrics 1991, 88:751-756.
105. Greffe BS, Marlar R, Manco-Johnson M Neonatal protein C: Molecular composition and distribution in normal term infants. Thromb Res 1989, 56:91-98.
106. Grosshaupt B, Muntean W, Sedlmayr P Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr 1997, 156:944-948.
107. Gruel Y, Boizard B, Daffos F, et al. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986, 68:488-492.
108. Gunther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in fullterm neonates: Role of acquired and genetic prothrombotic risk factors. Stroke 2000, 31:2437-2441.
109. Hakten M, Deniz U, Ozbay G, et al. Two cases of homozygous antithrombin III deficiency in a family with congenital deficiency of ATIII. Thrombosis and Haemorrhagic Disorders 1989, 177-181. Schmidt and Meyer Verlag, Wurzburg. H. Sinzinger, H. Vinazzer (Eds.).
110. Hansen KN, Ebbesen F Neonatal vitamin K prophylaxis in Denmark: Three years' experience with oral administration during the first three months of life compared with one oral administration at birth. Acta Paediatr 1996, 85:1137-1139.
111. Hardart GE, Fackler J Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation. J Pediatr 1999, 134:156-159.
112. Hartmann J, Hussein A, Trowitzsch E, et al. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001, 85:F18-F22.
113. Heikinheimo R Coagulation with fetal blood. Biol Neonate 1964, 7:319-327.
114. Heit JA, Silverstein M, Mohr D, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001, 86:452-463.
115. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factor. Br J Haematol 2000, 111:534-539.
116. Hensey OJ, Morgan M, Cooke R Tranexamic acid in the prevention of periventricular haemorrhage. Arch Dis Child 1984, 59:719-721.
117. Hirsh J Heparin. N Engl J Med 1991, 324:1565-1574.
118. Hirsh J, Dalen J, Guyatt G The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001, 119:1S-2S.
119. Hofmann S, Knoefler R, Lorenz N, et al. Clinical experiences with low-molecular weight heparins in pediatric patients. Thromb Res 2001, 103:345-353.
120. Hohlfeld P, Forestier F, Kaplan C, et al. Fetal thrombocytopenia: A retrospective survey of 5,194 fetal blood samplings. Blood 1994, 84:1851-1856.
121. Hord JD, Gay J, Whitlock J Thrombocytopenia in neonates with trisomy 21. Arch Pediatr Adolesc Med 1995, 149:824-825.
122. Hruszkewycz V, Holtrop PC, Batton D, et al. Complications associated with central venous catheters inserted in critically ill neonates. Inf Control Hosp Epidemiol 1991, 12:544-548.
123. Hume H, Blanchette V, Strauss R, et al. A survey of Canadian neonatal blood transfusion practices. Transfus Sci 1997, 18:71-80.
124. Hutter JJ, Hathaway W, Wayne E Hematologic abnormalities in severe neonatal necrotizing enterocolitis. J Pediatr 1976, 88:1026-1031.
125. Israels SJ, Cheang T, McMillan-Ward E, et al. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001, 138:116-119.
126. Israels SJ, Cheang T, Roberston C, et al. Impaired signal transduction in neonatal platelets. Pediatr Res 1999, 45:687-691.
127. Israels SJ, Daniels M, McMillan E Deficient collagen-induced activation in the newborn platelet. Pediatr Res 1990, 27:337-343.
128. Jochmans K, Lissens W, Vervoort R, et al. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994, 83:146-151.
129. Junker P, Egeblad M, Nielsen O, et al. Umbilical vein catheterization and portal hypertension. Acta Paediatr Scand 1976, 65:499-504.
130. Katz JA, Moake J, McPherson P, et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989, 73:1851-1858.
131. Kavakli K Fibrin glue and clinical impact on haemophilia care. Haemophilia 1999, 5:392-396.
132. Kazzi NJ, Ilagan N, Liang K, et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. Pediatrics 1989, 84:1045-1050.
133. Keller FG, DeFazio J, Jencks F, et al. The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous catheters. J Pediatr 1998, 132:165-167.
134. Kisker C Pathophysiology of bleeding disorders in the newborn. Fetal and Neonatal Physiology 1998, 1848-1861. WB Saunders, Philadelphia. R.A. Polin, W.W. Fox (Eds.).
135. Klesh KW, Murphy T, Scher M, et al. Cerebral infarction in persistent pulmonary hypertension of the newborn. Am J Dis Child 1987, 141:852-857.
136. Knofler R, Hofmann S, Weissbach G, et al. Molecular markers of the endothelium, the coagulation and the fibrinolytic systems in healthy newborns. Semin Thromb Hemost 1998, 24:453-461.
137. Knofler R, Weissbach G, Kuhlisch E Platelet function tests in childhood. Measuring aggregation and release reaction in whole blood. Semin Thromb Hemost 1998, 24:513-521.
138. Kreuz W, Veldmann A, Fischer D, et al. Neonatal sepsis: A challenge in hemostaseology. Semin Thromb Hemost 1999, 25:531-535.
139. Kuhle S, Lane D, Jochmanns K, et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost 2001, 86:1007-1011.
140. Kulkarni R, Lusher J Perinatal management of newborns with haemophilia. Br J Haematol 2001, 112:264-274.
141. Kulkarni R, Lusher J, Henry R, et al. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: A survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia 1999, 5:410-415.
142. Kumar D, Greer F, Super D, et al. Vitamin K status of premature infants: Implications for current recommendations. Pediatrics 2001, 108:1117-1122.
143. Kundu SK, Heilmann E, Sio R, et al. Description of an in vitro platelet function analyzer PFA-100. Semin Thromb Hemost 1995, 219(suppl 2):106-112.
144. Lesko SM, Mitchell A, Epstein M, et al. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med 1986, 314:1156-1160.
145. Levi M, ten Cate H Disseminated intravascular coagulation. N Engl J Med 1999, 341:586-592.
146. Levy SR, Abroms I, Marshall P, et al. Seizures and cerebral infarction in the fullterm newborn. Ann Neurol 1985, 17:366-370.
147. Ljung R, Lindgren A, Petrini P, et al. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994, 83:609-611.
148. Ljung RC Prenatal diagnosis of haemophilia. Haemophilia 1999, 5:84-87.
149. Loughnan PM, McDougall P Epidemiology of late onset haemorrhagic disease: A pooled data analysis. J Paediatr Child Health 1993, 29:177-181.
150. 1. J Paediatr Child Health 1996, 32:268-269.
151. Mahasandana C, Suvatte V, Chuansumrit A, et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990, 117:750-753.
152. Mahasandana C, Suvatte V, Marlar R, et al. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990, 335:61-62.
153. Male C, Chait P, Ginsberg J, et al. Comparison of venography and ultrasound for the diagnosis of deep vein thrombosis in the upper body in children: A substudy of the PARKAA trial. Thromb Haemost 2002, 87:593-598.
154. Malloy MH, Cutter G The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol 1995, 15:185-191.
155. Mannhalter C, Kyrle P, Brenner B, et al. Rapid neonatal diagnosis of type IIB von Willebrand disease using the polymerase chain reaction. Blood 1991, 77:2539-2540.
156. Marlar RA, Montgomery R, Broekmans A Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH Subcommittee on Protein C and Protein S. Thromb Haemost 1989, 61:529-531.
157. Marlar RA, Neumann A Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost 1990, 16:299-309.
158. Martin Montaner MI, Alzina de V, Arrufat Aranda, et al. [Thrombosis of the pulmonary artery associated with maternal deficiency of antithrombin III]. An Esp Pediatr 1987, 26:115-117.
159. Martinelli I, Bucciarelli P, Margaglione M, et al. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol 2000, 111:1223-1229.
160. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000, 21:347-352.
161. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998, 133:770-776.
162. Massicotte MP, Marzinotto V, Julian J, et al. Dose finding and pharmacokinetics of prophylactic doses of a low molecular weight heparin (reviparin™) in pediatric patients. Blood 1999, 94(pt 1 of 2). (Abstract).
163. Massicotte P, Adams M, Marzinotto V, et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996, 128:313-318.
164. Massicotte P, Leaker M, Marzinotto V, et al. Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thromb Haemost 1998, 80:570-574.
165. McDonald MM, Jacobson L, Hay W, et al. Heparin clearance in the newborn. Pediatr Res 1981, 15:1015-1018.
166. McNinch A, Tripp JH Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991, 303:1105-1109.
167. 1 in neonates. Arch Dis Child 1985, 60:814-818.
168. Mehta P, Vasa R, Neumann L, et al. Thrombocytopenia in the high-risk infant. J Pediatr 1980, 97:791-794.
169. Mehta S, Connors A, Danish E, et al. Incidence of thrombosis during central venous catheterization of newborns: A prospective study. J Pediatr Surg 1992, 27:18-22.
170. Menashi S, Aurousseau M, Gozin D, et al. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 1999, 81:906-909.
171. Ment LR, Ehrenkranz R, Duncan C Bacterial meningitis as an etiology of perinatal cerebral infarction. Pediatr Neurol 1986, 2:276-279.
172. Mercuri E, Cowan F, Gupte G, et al. Prothrombotic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001, 107:1400-1404.
173. Mercuri E, Cowan F, Rutherford M, et al. Ischaemic and haemorrhagic brain lesions in newborns with seizures and normal Apgar scores. Arch Dis Child Fetal Neonatal Ed 1995, 73:F67-F74.
174. Michaud JL, Rivard G, Chessex P Intracranial hemorrhage in a newborn with hemophilia following elective cesarean section. Am J Pediatr Hematol Oncol 1991, 13:473-475.
175. Miletich J, Sherman L, Broze G Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987, 317:991-996.
176. Miller M, Cosgriff J Hematological abnormalities in newborn infants with Down syndrome. Am J Med Genet 1983, 16:173-177.
177. Minford AM, Parapia L, Stainforth C, et al. Treatment of homozygous protein C deficiency with subcutaneous protein C concentrate. Br J Haematol 1996, 93:215-216.
178. Modanlou HD, Ortiz O Thrombocytopenia in neonatal infection. Clin Pediatr (Phila) 1981, 20:402-407.
179. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000, 47:763-766.
180. Monagle P, Andrew M, Halton J, et al. Homozygous protein C deficiency: Description of a new mutation and successful treatment with low molecular weight heparin. Thromb Haemost 1998, 79:756-761.
181. Monagle P, Michelson A, Bovill E, et al. Antithrombotic therapy in children. Chest 2001, 119:344S-370S.
182. Montaruli B, Schinco P, Pannocchia A, et al. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT. Thromb Haemost 1997, 78:1042-1048.
183. Morales WJ, Angel J, O'Brien W, et al. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage. Am J Obstet Gynecol 1988, 159:774-779.
184. Motohara K, Endo F, Matsuda I Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985, 2:242-244.
185. a. Vox Sang 1989, 57:90.
186. Mueller-Eckhardt C, Kiefel V, Grubert A 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989, 1:363-366.
187. Mueller-Eckhardt C, Santoso S, Kiefel V Platelet alloantigens molecular, genetic, and clinical aspects. Vox Sang 1994, 67(suppl 3):89-93.
188. Murphy MF, Waters A, Doughty H, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia report of 15 affected pregnancies. Transfus Med 1994, 4:281-292.
189. Murray NA, Roberts I Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and preterm neonates. Br J Haematol 1995, 89:41-46.
190. Murray NA, Watts TL, Roberts IA Inhibition of megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Blood 1994, 94:450a. (Abstract).
191. Murray NA, Watts T, Roberts I Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998, 43:148-151.
192. Nelson KB, Dambrosia J, Grether J, et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998, 44:665-675.
193. Neubauer AP Percutaneous central i.v. access in the neonate: Experience with 535 Silastic catheters. Acta Paediatr 1995, 84:756-760.
194. Nohe N, Flemmer A, Rumler R, et al. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: A report on 4 cases. Eur J Pediatr 1999, 158:S134-S139.
195. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: Outcome at 2 years. Lancet 1996, 348:229-232. The Northern Neonatal Nursing Initiative Trial Group.
196. Nowak-Gottl U, Koch H, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996, 92:992-998.
197. Nowak-Gottl U, Auberger K, Halimeh S, et al. Thrombolysis in newborns and infants. Thromb Haemost 1999, 82(suppl 1):112-116.
198. Nowak-Gottl U, Groll A, Kreuz WD, et al. Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection. Klin Padiatr (Germany) 1992, 204(3):134-140.
199. Nowak-Gottl U, Kohlhase B, Vielhaber H, et al. APC resistance in neonates and infants: Adjustment of the APTT-based method. Thromb Res 1996, 81:665-670.
200. Nowak-Gottl U, Von Kries R, Gobel U Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997, 76:F163-F167.
201. Nuss R, Hays T, Manco-Johnson M Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 1994, 16:127-131.
202. Oldenburg J, von Brederlow B, Fregin A, et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000, 84:937-941.
203. Parker L, Cole M, Craft A, et al. Neonatal vitamin K administration and childhood cancer in the north of England: Retrospective case-control study. BMJ 1998, 316:189-193.
204. Patel P, Weitz J, Brooker L, et al. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma. Pediatr Res 1996, 39:826-830.
205. Pegelow CH, Curless R, Bradford B Severe protein C deficiency in a newborn. Am J Pediatr Hematol Oncol 1988, 10:326-329.
206. Pellicer A, Cabanas F, Garcia-Alix A, et al. Stroke in neonates with cardiac right-to-left shunt. Brain Dev 1992, 14:381-385.
207. Petaja J, Hiltunen L, Fellman V Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatr Res 2001, 49:643-646.
208. Peterec SM, Brennan S, Rinder H, et al. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 1996, 129:269-274.
209. Peyvandi F, Mannucci P Rare coagulation disorders. Thromb Haemost 1999, 82:1207-1214.
210. Philip AG, Tito A Increased nucleated red blood cell counts in small for gestational age infants with very low birth weight. Am J Dis Child 1989, 143:164-169.
211. Pielet BW, Socol M, MacGregor S, et al. Cordocentesis: An appraisal of risks. Am J Obstet Gynecol 1988, 159:1497-1500.
212. Pollard AJ, Sreeram N, Wright J, et al. ECG and echocardiographic diagnosis of pulmonary thromboembolism associated with central venous lines. Arch Dis Child 1995, 73:147-150.
213. Pollmann H, Richter H, Ringkamp H, et al. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study. Eur J Pediatr 1999, 158(suppl 3):S166-S170.
214. 1: Effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage. Obstet Gynecol 1987, 70:235-241.
215. 9-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
216. Rais-Bahrami K, Short B The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000, 24:406-417.
217. 1) in preterm and sick neonates. Thromb Res 2000, 99:467-472.
218. Rajasekhar D, Barnard M, Bednarek F, et al. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997, 77:1002-1007.
219. Rajasekhar D, Kestin A, Bednarek F, et al. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994, 72:957-963.
220. Ramsey G, Salamon D Frequency of PLA1 in blacks. Transfusion 1986, 26:531-532.
221. Rand ML, Blanchette VS, Weitzman S Volume reduction of pre-storage leuko-reduced platelet concentrates does not affect platelet function in vitro or platelet recovery in vivo [abstract]. Blood 2001, 98:58a.
222. Randolph AG, Cook D, Gonzales C, et al. Benefit of heparin in central venous and pulmonary artery catheters: A meta-analysis of randomized controlled trials. Chest 1998, 113:165-171.
223. Rees CD, Cox M, Clegg JB World distribution of factor V Leiden. Lancet 1995, 346:1133-1134.
224. Reese J, Raghuveer T, Dennington P, et al. Breast feeding in neonatal alloimmune thrombocytopenia. J Paediatr Child Health 1994, 30:447-449.
225. Reverdiau-Moalic P, Delahousse B, Body G, et al. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996, 88:900-906.
226. Roddie PH, Stirling C, Mayne E, et al. Thrombosis and disseminated intravascular coagulation following treatment with the prothrombin complex concentrate, DEFIX. Thromb Haemost 1999, 81:667.
227. Rodeghiero F, Castaman G, Dini E Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987, 69:454-459.
228. Roschitz B, Sudi K, Kostenberger M, et al. Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 2001, 90:664-670.
229. Rosendaal FR, Koster T, Vandenbroucke J, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995, 85:1504-1508.
230. Ross JA, Davies S Vitamin K prophylaxis and childhood cancer. Med Pediatr Oncol 2000, 34:434-437.
231. Roy M, Turner-Gomes SO, Gill G Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Pediatr Res 1997, 41:173a. (Abstract).
232. Sainio S, Joutsi L, Jarvenpaa A, et al. Idiopathic thrombocytopenic purpura in pregnancy. Acta Obstet Gynecol Scand 1998, 77:272-277.
233. Salonvaara M, Riikonen P, Kekomaki R, et al. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr 1999, 88:642-646.
234. Sanchez J, Velasco F, Alvarez R, et al. Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: Successful outcome with thrombolytic and replacement treatment. Acta Paediatr 1998, 85:245-247.
235. Sanson BJ, Simioni P, Tormene D, et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999, 94:3702-3706.
236. Sanz-Rodriguez C, Gil-Fernandez J, Zapater P, et al. Long-term management of homozygous protein C deficiency: Replacement therapy with subcutaneous purified protein C concentrate. Thromb Haemost 1999, 81:887-890.
237. Saving KL, Jennings D, Aldag J, et al. Platelet ultrastructure of high-risk premature infants. Thromb Res 1994, 73:371-384.
238. Schabel A, Konig A, Brand U, et al. [Severe neonatal alloimmune thrombocytopenia with delayed antibody detection]. Beitr Infusionsther Transfusionsmed 1996, 33:156-159.
239. Schmidt B, Andrew M Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995, 96:939-943.
240. Schmidt B, Andrew M, Weitz J Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?. Thromb Haemost 1993, 69:418-421.
241. Schmidt B, Buchanan M, Ofosu F, et al. Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis. Thromb Haemost 1988, 60:289-292.
242. Schmidt B, Gillie P, Mitchell L, et al. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:470-476.
243. Schmidt B, Mitchell L, Ofosu F, et al. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 1989, 62:1074-1077.
244. Schmidt B, Ofosu F, Mitchell L, et al. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res 1989, 25:405-408.
245. 1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999, 158:599-602.
246. Schwartz DS, Gettner P, Konstantino M, et al. Umbilical venous catheterization and the risk of portal vein thrombosis. J Pediatr 1997, 131:760-762.
247. Schwarz HP, Muntean W, Watzke H, et al. Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood 1988, 71:562-565.
248. Seibert JJ, Taylor B, Williamson S, et al. Sonographic detection of neonatal umbilical-artery thrombosis: clinical correlation. Am J Roentgenol 1987, 148:965-968.
249. Setzer ES, Webb I, Wassenaar J, et al. Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant. J Pediatr 1982, 100:599-605.
250. Shah JK, Mitchell L, Paes B, et al. Thrombin inhibition is impaired in plasma of sick neonates. Pediatr Res 1992, 31:391-395.
251. Shapiro AD, Jacobson L, Aramon M, et al. Vitamin K deficiency in the newborn infant: Prevalence and perinatal risk factors. J Pediatr 1986, 109:675-680.
252. Shirahata A, Nakamura T, Shimono M, et al. Blood coagulation findings and the efficacy of factor XIII concentrate in premature infants with intracranial hemorrhages. Thromb Res 1990, 57:755-763.
253. Short BL, Walker L, Bender K, et al. Impairment of cerebral autoregulation during extracorporeal membrane oxygenation in newborn lambs. Pediatr Res 1993, 33:289-294.
254. Simioni P, Sanson B, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999, 81:198-202.
255. Sola MC, Calhoun D, Hutson A, et al. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999, 104:90-92.
256. Sola MC, Rimsza L, Christensen R A bone marrow biopsy technique suitable for use in neonates. Br J Haematol 1999, 107:458-460.
257. Solymar L, Rao P, Mardini M, et al. Prosthetic valves in children and adolescents. Am Heart J 1991, 121:557-568.
258. Spadone D Heparin induced thrombocytopenia in the newborn. J Vasc Surg 1996, 15:306-312.
259. Sreenan C, Bhargava R, Robertson C Cerebral infarction in the term newborn: Clinical presentation and long-term outcome. J Pediatr 2000, 137:351-355.
260. Srivastava A, Bruno E, Briddell R, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990, 76:1997-2004.
261. 1 in neonates is longer than is generally assumed: Implications for the prophylaxis of haemorrhaghic disease of the newborn. Eur J Clin Pharmacol 1996, 49:421-423.
262. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999, 94:3007-3014.
263. Suarez CR, Gonzalez J, Menendez C, et al. Neonatal and maternal platelets: Activation at time of birth. Am J Hematol 1988, 29:18-21.
264. Suarez CR, Walenga J, Mangogna L, et al. Neonatal and maternal fibrinolysis: Activation at time of birth. Am J Hematol 1985, 19:365-372.
265. Sutherland JM, Glueck H Hemorrhagic disease of the newborn; breast feeding as a necessary factor in the pathogenesis. Am J Dis Child 1967, 113:524-533.
266. Sutor AH, Dagres N, Niederhoff H Late form of vitamin K deficiency bleeding in Germany. Klin Padiatr 1995, 207:89-97.
267. Sutor AH, Von Kries R, Cornelissen E, et al. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999, 81:456-461.
268. Tait RC, Walker I, Perry D, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994, 87:106-112.
269. Tanindi S, Kurekci A, Koseoglu V, et al. The normalization period of platelet aggregation in newborns. Thromb Res 1995, 80:57-62.
270. Tanke RB, van Megen R, Daniels O Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994, 45:477-480.
271. Tate DY, Carlton G, Johnson D, et al. Immune thrombocytopenia in severe neonatal infections. J Pediatr 1981, 98:449-453.
272. Thaler E, Lechner K Antithrombin III deficiency and thromboembolism. Clin Haematol 1981, 10:369-390.
273. Thomas KB, Sutor A, Altinkaya N, et al. Von Willebrand factor-collagen binding activity is increased in newborns and infants. Acta Paediatr 1995, 84:697-699.
274. Thorp JA, Parriott J, Ferrette-Smith D, et al. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial. Obstet Gynecol 1994, 83:70-76.
275. Tomer A, Hanson S, Harker L Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. J Lab Clin Med 1991, 118:546-554.
276. Trauner DA, Chase C, Walker P, et al. Neurologic profiles of infants and children after perinatal stroke. Pediatr Neurol 1993, 9:383-386.
277. Ts'ao CH, Green D, Schultz K Function and ultrastructure of platelets of neonates: Enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 1976, 32:225-233.
278. Uhrynowska M, Maslanka K, Zupanska B Neonatal thrombocytopenia: Incidence, serological and clinical observations. Am J Perinatol 1997, 14:415-418.
279. Upp JR, Bush P, Zwischenberger J Complications of neonatal extracorporeal membrane oxygenation. Perfusion 1994, 9:241-256.
280. Urlesberger B, Zobel G, Zenz W, et al. Activation of the clotting system during extracorporeal membrane oxgenation in term newborn infants. J Pediatr 1996, 129:264-268.
281. Van de Bor BM, Briet E, Van Bel F, et al. Hemostasis and periventricular-intraventricular hemorrhage of the newborn. Am J Dis Child 1986, 140:1131-1134.
282. van der Meer FJ, Koster T, Vandenbroucke J, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997, 78:631-635.
283. van Leeuwen EF, Leeksma O, van Mourik J, et al. Effect of the binding of anti-Zwa antibodies on platelet function. Vox Sang 1984, 47:280-289.
284. van Ommen CH, Heijboer H, Buller H, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001, 139:676-681.
285. Vieira A, Berry L, Ofosu F, et al. Heparin sensitivity and resistance in the neonate: An explanation. Thromb Res 1991, 63:85-98.
286. Vielhaber H, Ehrenforth S, Koch H, et al. Cerebral venous sinus thrombosis in infancy and childhood: Role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr 1998, 157:555-560.
287. Vietti TJ, Murphy T, James J, et al. Observation on the prophylactic use of vitamin K in the newborn. J Pediatr 1960, 56:343-346.
288. Volpe JJ Neurology of the Newborn 2001, WB Saunders, Philadelphia. 3rd ed.
289. Von Kries R, Hanawa Y Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Committee on Perinatal Hemostasis. Thromb Haemost 1993, 69:293-295.
290. Von Kries R, Hachmeister A, Gobel U Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?. Eur J Pediatr 1999, 158(suppl 3):S183-186.
291. Weiner GM, Castle V, DiPietro M, et al. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 1998, 133:133-136.
292. Weissbach G, Harenberg J, Wendisch J, et al. Tissue factor pathway inhibitor in infants and children. Thromb Res 1994, 73:441-446.
293. A1, Zwa) as determined by antenatal screening. Blood 1998, 92:2280-2287.
294. Wright IM Prevention of intraventricular haemorrhage in preterm infants in Britain and Ireland. Arch Dis Child Fetal Neonatal Ed 1995, 72:F79.
295. 1 and its effect on coagulation in premature infants. J Pediatr 1989, 115:1009-1013.
296. Zenz W, Arlt F, Sodia S, et al. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 1997, 23:321-332.
297. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: First analysis of the Canadian Registry of VTE. Blood 1994, 83:1251-1257.
298. Andrew M, Paes B, Johnston M Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990, 12:95-104.
299. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the fullterm infant. Blood 1987, 70:165-172.
300. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988, 72:1651-1657.
301. Blanchette VS, Johnson J, Rand M The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol 2000, 13:365-390.
302. Bokenkamp A, von Kries R, Nowak-Gottl U, et al. Neonatal renal venous thrombosis in Germany between 1992 and 1994: Epidemiology, treatment and outcome. Eur J Pediatr 2000, 159:44-48.
303. Bussel JB Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 2001, 27:245-252.
304. Carcao MD, Blanchette V, Dean J, et al. The Platelet Function Analyzer (PFA-100): A novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998, 101:70-73.
305. Choi M, Massicotte M, Marzinotto V, et al. The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study. J Pediatr 2001, 139:152-156.
306. Dahlback B Blood coagulation. Lancet 2000, 355:1627-1632.
307. de Veber G, Andrew M Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 345:417-423.
308. George D, Bussel J Neonatal thrombocytopenia. Semin Thromb Hemost 1995, 21:276-293.
309. Gupta AA, Leaker M, Andrew M, et al. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 2001, 139:682-688.
310. Kuhne T, Imbach P Neonatal platelet physiology and pathophysiology. Eur J Pediatr 1998, 157:87-94.
311. Kulkarni R Bleeding in the newborn. Pediatr Ann 2001, 30:548-556.
312. Kulkarni R, Lusher J Perinatal management of newborns with haemophilia. Br J Haematol 2001, 112:264-274.
313. Lane DA, Grant P Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000, 95:1517-1532.
314. Massicotte MP Low-molecular-weight heparin therapy in children. J Pediatr Hematol Oncol 2001, 23:189-194.
315. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998, 133:770-776.
316. Mercuri E, Cowan F Cerebral infarction in the newborn infant: Review of the literature and personal experience. Europ J Paediatr Neurol 1999, 3:255-263.
317. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000, 47:763-766.
318. Monagle P, Michelson A, Bovill E, et al. Antithrombotic therapy in children. Chest 2001, 119:344S-370S.
319. Nowak-Gottl U, Auberger K, Halimeh S, et al. Thrombolysis in newborns and infants. Thromb Haemost 82 Suppl 1999, 1:112-116.
320. Nowak-Gottl U, von Kries R, Gobel U Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997, 76:F163-F167.
321. Roberts IA, Murray N Management of thrombocytopenia in neonates. Br J Haematol 1999, 105:864-870.
322. Roschitz B, Sudi K, Kostenberger M, et al. Shorter PFA-100 closure times in neonates than in adults: Role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 2001, 90:664-670.
323. Ross JA, Davies S Vitamin K prophylaxis and childhood cancer. Med Pediatr Oncol 2000, 34:434-437.
324. Schmidt B, Andrew M Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995, 96:939-943.
325. Schmidt B, Gillie P, Mitchell L, et al. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:470-476.
326. Sola MC, Del Vecchio A, Rimsza L Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 2000, 27:655-679.
327. Sutor AH, von Kries R, Cornelissen E, et al. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999, 81:456-461.
328. Van Ommen CH, Heijboer H, Buller HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in the Netherlands. J Pediatr 2001, 139:676-681.
329. Zipursky A Prevention of vitamin K deficiency bleeding in newborns. Br J Haematol 1999, 104:430-437.